JSA represented Vizag Hospital and Cancer Research Centre Private Limited (“Vizag Hospital”) and its shareholders in a transaction involving proposed sale of shares in Vizag Hospital to HealthCare Global Enterprises Limited (“HCG”), for an Enterprise Value of INR 4,140 Mn. The transaction is proposed to be completed in multiple tranches wherein HCG will acquire 51% of the equity share capital in Vizag Hospital in the first tranche and intends to complete the second tranche of acquisition of 34% of the equity share capital in the next 18 months. The acquisition of the balance 15% of the equity share capital in Vizag Hospital may be pursuant to a time bound call option or put option.
Vizag Hospital, owns and operates a comprehensive cancer care hospital in the city of Vishakhapatnam, Andhra Pradesh, with a well-built hospital infrastructure, led by Dr. Murali Krishna Voonna, a renowned onco-surgeon. The hospital boasts 196 operational beds and features advanced medical infrastructure, including 2 LINAC machines, 1 PET CT scanner, 1 Robotics Surgery System, and a dedicated Bone Marrow Transplant (BMT) unit. Its clinical team comprises 31 doctors, including 12 Surgical, 6 Radiation, and 4 Medical oncologists.
Deal value: Enterprise value of INR 4,140 Million
Our Transaction Team Comprised Lead Partner – Varun Sriram, Principal Associate – Varsha Srinivasan and Associate – Nandini Menon V.
Varsha’s practice in JSA focuses on M&A, banking & finance, and general corporate.